Artificial Intelligence's Impact on Drug Discovery and Development From Bench to Bedside

被引:7
|
作者
Vidhya, K. S. [1 ]
Sultana, Ayesha [2 ]
Kumar, M. Naveen [3 ]
Rangareddy, Harish [4 ]
机构
[1] Univ Visvesvaraya, Coll Engn, Bioinformat, Bangalore, India
[2] St Georges Univ, Sch Med, Pathol, St Georges, Grenada
[3] Haveri Inst Med Sci, Pharmacol, Haveri, India
[4] Haveri Inst Med Sci, Biochem, Haveri, India
关键词
drug discovery research; future of healthcare; nano technology; drug design; artificial intelligence in healthcare; LIPID NANOPARTICLES;
D O I
10.7759/cureus.47486
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Artificial intelligence (AI) techniques have the potential to revolutionize drug release modeling, optimize therapy for personalized medicine, and minimize side effects. By applying AI algorithms, researchers can predict drug release profiles, incorporate patient-specific factors, and optimize dosage regimens to achieve tailored and effective therapies. This AI-based approach has the potential to improve treatment outcomes, enhance patient satisfaction, and advance the field of pharmaceutical sciences. International collaborations and professional organizations play vital roles in establishing guidelines and best practices for data collection and sharing. Open data initiatives can enhance transparency and scientific progress, facilitating algorithm validation.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Biotechnology and drug discovery: From bench to bedside
    Avidor, Y
    Mabjeesh, NJ
    Matzkin, H
    [J]. SOUTHERN MEDICAL JOURNAL, 2003, 96 (12) : 1174 - 1186
  • [2] Impact of Artificial Intelligence (AI) on Drug Discovery and Product Development
    Narayanan, Ravi Ram
    Durga, Narayanamoorthy
    Nagalakshmi, Sethuraman
    [J]. INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2022, 56 (03) : S387 - S397
  • [3] From bench to bedside: ways and steps of drug discovery
    Alkan, S. S.
    [J]. THALASSEMIA REPORTS, 2011, 1 (01) : 100 - 101
  • [4] Drug Discovery for CNS Disorders: From Bench to Bedside
    Kazantsev, Aleksey G.
    Outeiro, Tiago Fleming
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2010, 9 (06) : 668 - 668
  • [5] Artificial intelligence in drug discovery and development
    Paul, Debleena
    Sanap, Gaurav
    Shenoy, Snehal
    Kalyane, Dnyaneshwar
    Kalia, Kiran
    Tekade, Rakesh K.
    [J]. DRUG DISCOVERY TODAY, 2020, 26 (01) : 80 - 93
  • [6] FROM BENCH TO BEDSIDE - BIOLOGIST IN DRUG DEVELOPMENT
    MCKINNEY, GR
    STAVELY, HE
    [J]. BIOSCIENCE, 1966, 16 (10) : 683 - &
  • [7] Editorial: Artificial intelligence in drug discovery and development
    Wei, Leyi
    Zou, Quan
    Zeng, Xiangxiang
    [J]. METHODS, 2024, 226 : 133 - 137
  • [8] The drug development process - From the bench to bedside and back
    Tauscher, J.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S25 - S26
  • [9] Managing strategies for diverse diseases: Challenges from bench to bedside in successful drug discovery and development
    Bobryshev, Yuri V.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (25) : 3567 - 3567
  • [10] From byte to bench to bedside: molecular dynamics simulations and drug discovery
    Ahmed, Mayar
    Maldonado, Alex M.
    Durrant, Jacob D.
    [J]. BMC BIOLOGY, 2023, 21 (01)